Reflecting back on what we saw and heard at ASH 15, IMF support group leaders (SGLs) left Orlando with great hope for success against myeloma. Three new drug approvals in the two weeks preceding ASH were the talk of the meeting. Direct attack on myeloma cells by monoclonal antibodies gives us a new weapon with […]